Preparation and Biological Characterization of Polymeric Micelle Drug Carriers with Intracellular pH-Triggered Drug Release Property: Tumor Permeability, Controlled Subcellular Drug Distribution, and Enhanced in Vivo Antitumor Efficacy
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
A novel intracellular pH-sensitive polymeric micelle drug carrier that controls the systemic, local, and subcellular distributions of pharmacologically active drugs has been developed in this study. The micelles were prepared from self-assembling amphiphilic block copolymers, poly(ethylene glycol)-poly(aspartate hydrazone adriamycin), in which the anticancer drug, adriamycin, was conjugated to the hydrophobic segments through acid-sensitive hydrazone linkers. By this polymer design, the micelles can stably preserve drugs under physiological conditions (pH 7.4) and selectively release them by sensing the intracellular pH decrease in endosomes and lysosomes (pH 5-6). In vitro and in vivo studies show that the micelles have the characteristic properties, such as an intracellular pH-triggered drug release capability, tumor-infiltrating permeability, and effective antitumor activity with extremely low toxicity. The acquired experimental data clearly elucidate that the optimization of both the functional and structural features of polymeric micelles provides a promising formulation not only for the development of intracellular environment-sensitive supramolecular devices for cancer therapeutic applications but also for the future treatment of intractable cancers with limited vasculature.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This same concept was used by Kataoka and colleagues in a series of works leading to development of polymeric micelle NK911, which was evaluated clinically [146, 147].”
From Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. (2020) · cites this paper as [147]
In the citing paper
“A study by the Kataoka group showed the development of pH sensitive drug release from PEG-b-P(aspartate hydrazone adriamycin) [147].”
From Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. (2020) · cites this paper as [147]
In the citing paper
“This kind of technology can improve drug targeting abilities by only allowing drug release from the micelles under certain external stimuli.”
From Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. (2020) · cites this paper as [147]
Citations
Cites
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565
Self-citationBlock copolymer micelles for drug delivery: design, characterization and biological significance
Kataoka, K., Harada, A., & Nagasaki, Y. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00124-1 · Cited by 3,506
Self-citationThe dawning era of polymer therapeutics
Duncan, R. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1088 · Cited by 3,269
Amphiphilic block copolymers for drug delivery
Adams, M. L., Lavasanifar, A., & Kwon, G. S. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10397 · Cited by 1,078
Trends and Developments in Liposome Drug Delivery Systems
Lian, T., & Ho, R. J. Y. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.1023 · Cited by 907
SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy
Maeda, H. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00134-4 · Cited by 662
Development of the polymer micelle carrier system for doxorubicin
Nakanishi, T., Fukushima, S., Okamoto, K., Suzuki, M., Matsumura, Y., Yokoyama, M., Okano, T., Sakurai, Y., & Kataoka, K. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00341-8 · Cited by 570
Self-citationPolymeric anticancer drugs with pH-controlled activation
Ulbrich, K. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.040 · Cited by 494
Yamamoto, Y., Nagasaki, Y., Kato, Y., Sugiyama, Y., & Kataoka, K. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00451-5 · Cited by 442
Self-citationKwon, G., Suwa, S., Yokoyama, M., Okano, T., Sakurai, Y., & Kataoka, K. (1994) · Journal of Controlled Release · doi:10.1016/0168-3659(94)90118-x · Cited by 409
Self-citation
Research works printed but not linked: 20
- Jain R. K., 2001, Adv. Drug Delivery Rev., 46
- Nishiyama N., 2003, Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice. Cancer Res. 63, 8977−8983
- Lewanski C. R. I., 1999, PEGylated liposomal adriamycin: a review of current and future applications. Pharm. Sci. Technol. Today 2, 473−477
- Kataoka K., 1993, J. Controlled Release, 24
- Ringsdorf H., 1975, J. Polym. Sci. Polym. Symp. 51
- Vasey P. A., 1999, Clin. Cancer Res., 5, 94
- Gordon A. N., 2001, J. Clin. Oncol., 19
- Jain R. K., 1994, Sci. Am., 271, 65
- Takakura Y., 1996, Macromolecular carrier systems for targeted drug delivery: Pharmacokinetic considerations on biodistribution. Pharm. Res. 13, 820−831
- Dvorak H. F., 1998, Am. J. Pathol., 133, 109
- D'souza A. J. M., 2004, J. Pharm. Sci., 93
- Willner D., 1993, (6-Maleimidocaproyl)hydrazone of doxorubicin. A new derivative for the preparation of immunoconjugates of doxorubicin. Bioconjugate Chem. 4, 521−527
- Kaneko T., 1991, New hydrazone derivatives of adriamycin and their immunoconjugates − a correlation between acid stability and cytotoxicity. Bioconjugate Chem. 2, 133−141
- Sutherland R. M., 1988, Cell and environment interactions in tumor microregions: the multicell spheroid model. Science 240, 177−184
- Matsumura Y., 1986, A new concept of macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent SMANCS. Cancer Res. 46, 6387−6392
- Jain R. K., 1988, Determinants of tumor blood flow: a review. Cancer Res. 48, 2641−2658
- Baxter L. T., 1994, Physiologically based pharmacokinetic model for specific and nonspecific monoclonal antibodies and fragments in normal tissues and human tumor xenografts in nude mice. Cancer Res. 54, 1517−1528
- Nishiyama N., 2001, Cisplatin-loaded polymer−metal complex micelle with time-modulated decaying property as a novel drug delivery system. Pharmaceut. Res. 18, 1035−1041
- Torchilin V. P., 2003, Immunomicelles: Targeted pharmaceutical carriers for poorly soluble drugs. P. Natl. Acad. Sci. USA. 100, 6039−6044
- Emanuel N., 1996, Targeted delivery of doxorubicin via sterically stabilized immunoliposomes: Pharmacokinetics and biodistribution in tumor-bearing mice. Pharm. Res. 13, 861−868
Cited by
Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size
Cabral, H., Matsumoto, Y., Mizuno, K., Chen, Q., Murakami, M., Kimura, M., Terada, Y., Kano, M. R., Miyazono, K., Uesaka, M., et al. (2011) · Nature Nanotechnology · doi:10.1038/nnano.2011.166 · Cited by 2,429
Self-citationA review of stimuli-responsive nanocarriers for drug and gene delivery
Ganta, S., Devalapally, H., Shahiwala, A., & Amiji, M. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.12.017 · Cited by 2,155
Tumor delivery of macromolecular drugs based on the EPR effect
Torchilin, V. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.03.011 · Cited by 2,032
Polymer conjugates as anticancer nanomedicines
Duncan, R. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1958 · Cited by 1,962
Micellar Nanocarriers: Pharmaceutical Perspectives
Torchilin, V. P. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9132-0 · Cited by 1,910
Ulbrich, K., Holá, K., Šubr, V., Bakandritsos, A., Tuček, J., & Zbořil, R. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00589 · Cited by 1,730
Polymers for Drug Delivery Systems
Liechty, W. B., Kryscio, D. R., Slaughter, B. V., & Peppas, N. A. (2010) · Annual Review of Chemical and Biomolecular Engineering · doi:10.1146/annurev-chembioeng-073009-100847 · Cited by 1,608
Nanocarriers’ entry into the cell: relevance to drug delivery
Hillaireau, H., & Couvreur, P. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0053-z · Cited by 1,552
Block copolymer micelles: preparation, characterization and application in drug delivery
Gaucher, G., Dufresne, M.-H., Sant, V. P., Kang, N., Maysinger, D., & Leroux, J.-C. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.09.034 · Cited by 1,498
Applications of Orthogonal “Click” Chemistries in the Synthesis of Functional Soft Materials
Iha, R. K., Wooley, K. L., Nyström, A. M., Burke, D. J., Kade, M. J., & Hawker, C. J. (2009) · Chemical Reviews · doi:10.1021/cr900138t · Cited by 1,468
Block copolymer micelles in nanomedicine applications
Cabral, H., Miyata, K., Osada, K., & Kataoka, K. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00199 · Cited by 1,309
Self-citationBiodegradable synthetic polymers: Preparation, functionalization and biomedical application
Tian, H., Tang, Z., Zhuang, X., Chen, X., & Jing, X. (2012) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2011.06.004 · Cited by 1,293
The unique role of nanoparticles in nanomedicine: imaging, drug delivery and therapy
Doane, T. L., & Burda, C. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15260f · Cited by 1,098
Nishiyama, N., & Kataoka, K. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.05.006 · Cited by 1,052
Self-citationPhysical stimuli-responsive polymeric micelles for anti-cancer drug delivery
Rapoport, N. (2007) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2007.05.009 · Cited by 1,002
Polymeric Micelles in Anticancer Therapy: Targeting, Imaging and Triggered Release
Oerlemans, C., Bult, W., Bos, M., Storm, G., Nijsen, J. F. W., & Hennink, W. E. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0233-4 · Cited by 947
Progress of drug-loaded polymeric micelles into clinical studies
Cabral, H., & Kataoka, K. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.042 · Cited by 837
Self-citationBiocompatibility of engineered nanoparticles for drug delivery
Naahidi, S., Jafari, M., Edalat, F., Raymond, K., Khademhosseini, A., & Chen, P. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.12.013 · Cited by 809
Targeted pharmaceutical nanocarriers for cancer therapy and imaging
Torchilin, V. P. (2007) · The AAPS Journal · doi:10.1208/aapsj0902015 · Cited by 762
Fang, J., Islam, W., & Maeda, H. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.005 · Cited by 757
Role of nanotechnology in targeted drug delivery and imaging: a concise review
Koo, O. M., Rubinstein, I., & Onyuksel, H. (2005) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2005.06.004 · Cited by 718
Cancer nanotechnology: application of nanotechnology in cancer therapy
Misra, R., Acharya, S., & Sahoo, S. K. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.08.006 · Cited by 702
Hwang, D., Ramsey, J. D., & Kabanov, A. V. (2020) · Advanced drug delivery reviews · doi:10.1016/j.addr.2020.09.009 · Cited by 699
Bae, Y., & Kataoka, K. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.04.016 · Cited by 669
Self-citationStimuli-responsive polymers and their applications in drug delivery
Bawa, P., Pillay, V., Choonara, Y. E., & du Toit, L. C. (2009) · Biomedical Materials · doi:10.1088/1748-6041/4/2/022001 · Cited by 641
Multifunctional and stimuli-sensitive pharmaceutical nanocarriers
Torchilin, V. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.09.026 · Cited by 583
Polymeric Conjugates for Drug Delivery
Larson, N., & Ghandehari, H. (2012) · Chemistry of Materials · doi:10.1021/cm2031569 · Cited by 580
Andrew MacKay, J., Chen, M., McDaniel, J. R., Liu, W., Simnick, A. J., & Chilkoti, A. (2009) · Nature Materials · doi:10.1038/nmat2569 · Cited by 580
Josefsen, L. B., & Boyle, R. W. (2012) · Theranostics · doi:10.7150/thno.4571 · Cited by 575
Passive and Active Drug Targeting: Drug Delivery to Tumors as an Example
Torchilin, V. P. (2010) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-00477-3_1 · Cited by 573
Deng, C., Jiang, Y., Cheng, R., Meng, F., & Zhong, Z. (2012) · Nano Today · doi:10.1016/j.nantod.2012.08.005 · Cited by 562
Functionalized micellar systems for cancer targeted drug delivery
Sutton, D., Nasongkla, N., Blanco, E., & Gao, J. (2007) · Pharmaceutical Research · doi:10.1007/s11095-006-9223-y · Cited by 557
RECENT APPROACHES TO INTRACELLULAR DELIVERY OF DRUGS AND DNA AND ORGANELLE TARGETING
Torchilin, V. P. (2006) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.8.061505.095735 · Cited by 543
Han, X., Huang, J., Lin, H., Wang, Z., Li, P., & Chen, Y. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201701394 · Cited by 508
Mechanisms of drug release in nanotherapeutic delivery systems
Wong, P. T., & Choi, S. K. (2015) · Chemical Reviews · doi:10.1021/cr5004634 · Cited by 507
Rijcken, C. J. F., Soga, O., Hennink, W. E., & Nostrum, C. F. V. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.03.023 · Cited by 487
Tyrrell, Z. L., Shen, Y., & Radosz, M. (2010) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2010.06.003 · Cited by 481
pH-sensitive vesicles, polymeric micelles, and nanospheres prepared with polycarboxylates
Felber, A. E., Dufresne, M.-H., & Leroux, J.-C. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.09.006 · Cited by 478
Design and development of polymeric micelles with cleavable links for intracellular drug delivery
Wei, H., Zhuo, R.-X., & Zhang, X.-Z. (2013) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2012.07.002 · Cited by 474
Extracellularly Activated Nanocarriers: A New Paradigm of Tumor Targeted Drug Delivery
Gullotti, E., & Yeo, Y. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900090z · Cited by 473
Recent advances in polymeric micelles for anti-cancer drug delivery
Biswas, S., Kumari, P., Lakhani, P. M., & Ghosh, B. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2015.12.031 · Cited by 471
Self-assembling materials for therapeutic delivery
Branco, M. C., & Schneider, J. P. (2009) · Acta Biomaterialia · doi:10.1016/j.actbio.2008.09.018 · Cited by 462
Release mechanisms for polyelectrolyte capsules
De Geest, B. G., Sanders, N. N., Sukhorukov, G. B., Demeester, J., & De Smedt, S. C. (2007) · Chem. Soc. Rev. · doi:10.1039/b600460c · Cited by 462
Lee, E. S., Oh, K. T., Kim, D., Youn, Y. S., & Bae, Y. H. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.08.006 · Cited by 446
Self-citationBae, Y., Jang, W.-D., Nishiyama, N., Fukushima, S., & Kataoka, K. (2005) · Molecular BioSystems · doi:10.1039/b500266d · Cited by 445
Self-citationRelease Mechanisms for Polyelectrolyte Capsules
De Geest, B. G., Sanders, N. N., Sukhorukov, G. B., Demeester, J., & De Smedt, S. C. (2007) · ChemInform · doi:10.1002/chin.200724277 · Cited by 430
Acid-degradable polymers for drug delivery: a decade of innovation
Binauld, S., & Stenzel, M. H. (2013) · Chemical Communications · doi:10.1039/c2cc36589h · Cited by 421
Smart drug delivery systems: from fundamentals to the clinic
Alvarez-Lorenzo, C., & Concheiro, A. (2014) · Chem. Commun. · doi:10.1039/c4cc01429d · Cited by 415
Kano, M. R., Bae, Y., Iwata, C., Morishita, Y., Yashiro, M., Oka, M., Fujii, T., Komuro, A., Kiyono, K., Kaminishi, M., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611660104 · Cited by 410
Self-citationA Review of Polymeric Micelles and Their Applications
Perumal, S., Atchudan, R., & Lee, W. (2022) · Polymers · doi:10.3390/polym14122510 · Cited by 390
Biofunctional polymer nanoparticles for intra-articular targeting and retention in cartilage
Rothenfluh, D. A., Bermudez, H., O’Neil, C. P., & Hubbell, J. A. (2008) · Nature Materials · doi:10.1038/nmat2116 · Cited by 388
Stimuli‐Responsive Materials for Controlled Release of Theranostic Agents
Wang, Y., Shim, M. S., Levinson, N. S., Sung, H., & Xia, Y. (2014) · Advanced Functional Materials · doi:10.1002/adfm.201400279 · Cited by 378
Cheetham, A. G., Chakroun, R. W., Ma, W., & Cui, H. (2017) · Chem. Soc. Rev. · doi:10.1039/c7cs00521k · Cited by 367
Nanovehicular Intracellular Delivery Systems
Prokop, A., & Davidson, J. M. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21270 · Cited by 363
Cheng, Y.-H., He, C., Riviere, J. E., Monteiro-Riviere, N. A., & Lin, Z. (2020) · ACS Nano · doi:10.1021/acsnano.9b08142 · Cited by 362
Lee, H., Fonge, H., Hoang, B., Reilly, R. M., & Allen, C. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100038h · Cited by 349
Revisiting structure-property relationship of pH-responsive polymers for drug delivery applications
Bazban-Shotorbani, S., Hasani-Sadrabadi, M. M., Karkhaneh, A., Serpooshan, V., Jacob, K. I., Moshaverinia, A., & Mahmoudi, M. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.02.021 · Cited by 342
Stimuli‐Sensitive Synthetic Polypeptide‐Based Materials for Drug and Gene Delivery
He, C., Zhuang, X., Tang, Z., Tian, H., & Chen, X. (2012) · Advanced Healthcare Materials · doi:10.1002/adhm.201100008 · Cited by 337
Multifunctional Micellar Nanomedicine for Cancer Therapy
Blanco, E., Kessinger, C. W., Sumer, B. D., & Gao, J. (2009) · Experimental Biology and Medicine · doi:10.3181/0808-mr-250 · Cited by 332
Torchilin, V. P. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.031 · Cited by 332
Ahmed, F., Pakunlu, R. I., Srinivas, G., Brannan, A., Bates, F., Klein, M. L., Minko, T., & Discher, D. E. (2006) · Molecular Pharmaceutics · doi:10.1021/mp050103u · Cited by 330
Mikhail, A. S., & Allen, C. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.04.010 · Cited by 328
pH ‐Sensitive stimulus‐responsive nanocarriers for targeted delivery of therapeutic agents
Karimi, M., Eslami, M., Sahandi‐Zangabad, P., Mirab, F., Farajisafiloo, N., Shafaei, Z., Ghosh, D., Bozorgomid, M., Dashkhaneh, F., & Hamblin, M. R. (2016) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1389 · Cited by 327
Nanoparticles: Functionalization and Multifunctional Applications in Biomedical Sciences
Subbiah, R., Veerapandian, M., & S. Yun, K. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710794183024 · Cited by 327
Hydrazone linkages in pH responsive drug delivery systems
Sonawane, S. J., Kalhapure, R. S., & Govender, T. (2017) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2016.12.011 · Cited by 320
Anticancer nanomedicine and tumor vascular permeability; Where is the missing link?
Taurin, S., Nehoff, H., & Greish, K. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.07.013 · Cited by 309
Ko, J., Park, K., Kim, Y.-S., Kim, M. S., Han, J. K., Kim, K., Park, R.-W., Kim, I.-S., Song, H. K., Lee, D. S., et al. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.07.012 · Cited by 302
Hamley, I. W. (2014) · Biomacromolecules · doi:10.1021/bm500246w · Cited by 300
Polymeric Nanocarriers of Drug Delivery Systems in Cancer Therapy
Avramović, N., Mandić, B., Savić-Radojević, A., & Simić, T. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12040298 · Cited by 296
Recent trends in the design of anticancer polymer prodrug nanocarriers
Delplace, V., Couvreur, P., & Nicolas, J. (2014) · Polym. Chem. · doi:10.1039/c3py01384g · Cited by 287
Bae, Y., Nishiyama, N., & Kataoka, K. (2007) · Bioconjugate Chemistry · doi:10.1021/bc060401p · Cited by 278
Self-citationMXene in the lens of biomedical engineering: synthesis, applications and future outlook
Zamhuri, A., Lim, G. P., Ma, N. L., Tee, K. S., & Soon, C. F. (2021) · BioMedical Engineering OnLine · doi:10.1186/s12938-021-00873-9 · Cited by 277
Applications of polymer micelles for imaging and drug delivery
Movassaghian, S., Merkel, O. M., & Torchilin, V. P. (2015) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1332 · Cited by 276
Nanomicelles: types, properties and applications in drug delivery
Bose, A., Roy Burman, D., Sikdar, B., & Patra, P. (2021) · IET Nanobiotechnology · doi:10.1049/nbt2.12018 · Cited by 278
Wang, Z., Deng, X., Ding, J., Zhou, W., Zheng, X., & Tang, G. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.11.003 · Cited by 269
Carbohydrates in Supramolecular Chemistry
Delbianco, M., Bharate, P., Varela-Aramburu, S., & Seeberger, P. H. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00516 · Cited by 268
Felix Sahayaraj, A., Joy Prabu, H., Maniraj, J., Kannan, M., Bharathi, M., Diwahar, P., & Salamon, J. (2023) · Journal of Inorganic and Organometallic Polymers and Materials · doi:10.1007/s10904-023-02657-1 · Cited by 267
Nishiyama, N., Morimoto, Y., Jang, W.-D., & Kataoka, K. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.01.004 · Cited by 266
Self-citationpH-sensitive biomaterials for drug delivery
Zhuo, S., Zhang, F., Yu, J., Zhang, X., Yang, G., & Liu, X. (2020) · Molecules · doi:10.3390/molecules25235649 · Cited by 247
Osada, K., Christie, R. J., & Kataoka, K. (2009) · Journal of The Royal Society Interface · doi:10.1098/rsif.2008.0547.focus · Cited by 218
Self-citationPolymeric micelles of biodegradable diblock copolymers: enhanced encapsulation of hydrophobic drugs
Hussein, Y. H. A., & Youssry, M. (2018) · Materials · doi:10.3390/ma11050688 · Cited by 196
Liu, R., Li, D., He, B., Xu, X., Sheng, M., Lai, Y., Wang, G., & Gu, Z. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.02.031 · Cited by 157
Enhanced Release of Small Molecules from Near-Infrared Light Responsive Polymer−Nanorod Composites
Hribar, K. C., Lee, M. H., Lee, D., & Burdick, J. A. (2011) · ACS Nano · doi:10.1021/nn103575a · Cited by 155
Recent Advances in Nanomicelles Delivery Systems.
Tawfik, S. M., Azizov, S., Elmasry, M. R., Sharipov, M., & Lee, Y.-I. (2020) · Nanomaterials · doi:10.3390/nano11010070 · Cited by 156
“, discharge selectively in the strong acidic medium because of pH-sensitive hydrazine group [159].”
BackgroundNexus between in silico and in vivo models to enhance clinical translation of nanomedicine
Moradi Kashkooli, F., Soltani, M., Souri, M., Meaney, C., & Kohandel, M. (2021) · Nano Today · doi:10.1016/j.nantod.2020.101057 · Cited by 120
Solomon, M. A., Lemera, J., & D’Souza, G. G. M. (2016) · Journal of Liposome Research · doi:10.3109/08982104.2015.1105820 · Cited by 30
Gupta, A., Kaur, C. D., Saraf, S., & Saraf, S. (2017) · Journal of Receptors and Signal Transduction · doi:10.3109/10799893.2016.1147581 · Cited by 27
Assessing the benefits of drug delivery by nanocarriers: a partico/pharmacokinetic framework
Siegel, R. A., Kirtane, A. R., & Panyam, J. (2017) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2016.2632733 · Cited by 14
Metadata
- Authors
- Bae, Y., Nishiyama, N., Fukushima, S., Koyama, H., Yasuhiro, M., & Kataoka, K.
- Affiliations
- National Cancer Center Hospital East (JP)
- Department of Materials Science and Engineering, Graduate School of Engineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8656, Japan, Department of Clinical Vascular Regeneration, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan, and Investigative Treatment Division, National Cancer Center Research Institute East, 6-5-1 Kashiwanoha, Kashiwa, Chiba 277-8577, Japan
- Corresponding author
- Kataoka, Kazunori
- Venue
- Bioconjugate Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2004-12-22
- Volume
- 16
- Issue
- 1
- Pages
- 122-130
- ISSN
- 1043-1802 (ISSN-L)
- 1520-4812
- OpenAlex
- W2169187623
- Cited by
- 742
- References
- 23
- Citations by year
- 2026: 9 · 2025: 19 · 2024: 13 · 2023: 22 · 2022: 25 · 2021: 27 · 2020: 41 · 2019: 25 · 2018: 24 · 2017: 43 · 2016: 48 · 2015: 47 · 2014: 60 · 2013: 56 · 2012: 55
- FWCI
- 10.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Bioconjugate Chemistry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Cancer Research Institute
- Japan Science and Technology Corporation
- Core Research for Evolutional Science and Technology
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Materials Science › Polymers and Plastics › Dendrimers and Hyperbranched Polymers
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Keywords
- polymeric micelles, pH-responsive drug release, intracellular pH, doxorubicin, hydrazone linkers, amphiphilic block copolymers, tumor permeability, subcellular drug distribution, antitumor efficacy, drug delivery systems
- MeSH terms
- Animals, Antineoplastic Agents, Doxorubicin, Drug Carriers, Hydrazones, Hydrogen-Ion Concentration, Lysosomes, Micelles, Neoplasms, Experimental, Organ Specificity, Permeability, Polyethylene Glycols, Polymers, Endosomes, Time Factors, Tumor Cells, Cultured, Drug Delivery Systems, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.